Korea: HK Inno.N prices Korea IPO at top of range to raise W596bn

HK Inno.N (formerly CJHealthCare), a Korean-based global biohealth company and manufactuer of the country’s favourite anti-hangover drink, has raised W596bn (US$516m) through a share offering. The IPO consisted of 10.1 million shares, marketed at W50,000 – W59,000. It was priced at the top of the range, according to IFR, to value the company at W1.7trn….

You must be a HMI Subscriber to view this content.

Subscribe Now »